Featured series 
Tag: Shiladitya Sengupta
-
Nation & World
Metastasis study illuminates how cancer will ‘hijack’ healthy cells
A study from Brigham and Women’s Hospital offers a new view of how cancer cells extend their reach, co-opting and transforming normal cells through “metastatic hijacking.” The researchers also found that in preclinical models, pharmacological intervention can prevent this from occurring.
-
Nation & World
Using nanotechnology to improve a cancer treatment
Harvard and Brigham and Women’s Hospital researchers have devised a method that may allow clinicians to use higher doses of a powerful chemotherapy drug that has been limited because it is toxic not only to tumors but to patients’ kidneys.
-
Nation & World
Improving a cancer drug
Researchers, led by Harvard Medical School Assistant Professor Shiladitya Sengupta, have devised a way to improve a low-cost, effective cancer drug, cisplatin, whose use has been limited by its toxicity.
-
Nation & World
A more direct delivery of cancer drugs to tumors
An interdisciplinary team of researchers at Brigham and Women’s Hospital (BWH) and the Harvard-MIT Division of Health Sciences and Technology (HST) has demonstrated a better way to deliver cancer drugs…
-
Nation & World
Medical basics still needed in Developing World
Despite all the progress and promise of modern medicine, most of the world is still struggling to get the fundamentals of medical care: simple diagnostic tests, affordable medicines, and efficient…